A high dose (1-2.5 × 10 10 infectious units) of recombinant vated astrocytes (gliosis). Immunohistochemical analysis adenovirus harboring the herpes simplex thymidine kinase of the infiltrates revealed the presence of predominantly gene (IG.Ad.MLPI.TK) was injected into the white matter mononuclear cells. In the vicinity of the lesion perivascular of the right frontal lobe in two rhesus monkeys (M. mulatta).
Introduction
Replication-deficient adenovirus vectors can successfully transfer genes into neurons and glial cells both in vitro and in vivo. [1] [2] [3] [4] [5] Further, effectivity of suicide gene therapy in the treatment of experimental rat brain tumors, using adenoviral vectors harboring the herpes simplex virus thymidine kinase (HSVtk) gene combined with systemic ganciclovir (GCV) administration has been demonstrated. [6] [7] [8] [9] [10] The TK/GCV combination therapy is based on the monophosphorylation of the nucleoside analogue GCV by HSV-TK. In turn, GCV-monophosphate is converted by cellular enzymes into a triphosphate compound that inhibits DNA synthesis by acting as a chain terminator, killing dividing cells. 11 To achieve complete tumor eradication only 10% tumor cell transduction was found to be sufficient. This phenomenon is attributed to the 'bystander effect' which means that cells in close proximity to TK expressing cells also become sensitive to GCV. [12] [13] [14] [15] In vitro experiments suggest that it may be caused by the transfer of phosphorylated GCV to nontransduced cells via gap junctions or by phagocytosis of apoptotic vesicles, containing GCV metabolites, by the nontransduced bystanding cells. [16] [17] [18] [19] [20] In vivo, antitumor immunity induced by TK/GCV may contribute to the bystander effect. [21] [22] [23] [24] The use of adenoviral vectors in clinical gene therapy, however, may be limited by toxic effects to surrounding normal tissues. Local administration of replication defective adenovirus vectors to the brain (and visceral organs) induces an inflammatory reaction by eliciting a biphasic immune response. [25] [26] [27] [28] [29] The early, innate, phase of the immune response is characterized by infiltration of neutrophils and macrophages and is followed by a T celldependent adaptive immune response. The immune response is not only toxic but also contributes to the decline of transgene expression because of the elimination of infected or transduced cells by cytotoxic T cells. [25] [26] [27] [28] [29] [30] [31] Goodman et al 32 observed significant neurotoxicity of adenotk, potentiated by GCV, in baboons. Two animals in which the intracerebral injection of a high dose of adenotk was followed by treatment with GCV died from increased intracranial pressure. At necropsy necrotic cavities were found at the injection sites.
Before initiating a phase 1 clinical trial in patients with malignant gliomas we examined the neurotoxicity of our vector, IG.Ad.MLPI.TK, in nonhuman primates. We injected a high dose of IG.Ad.MLPI.TK into the brain of two rhesus monkeys (Macaca mulatta, RM1 and RM2). RM1 received 1.0 × 10 10 IU (= 4.2 × 10 11 particles) and RM2 received 2.5 × 10 10 IU (= 1.1 × 10 12 particles). After 48 h, virus injection was followed by systemic GCV administration for 14 days and at day 18 the animals were killed.
Results

Clinical observations
Clinically, both monkeys were doing well during the experiment. No toxic effects of the TK/GCV combination could be observed. Following virus injection none of the animals showed neurological symptoms and no behavioral or motor changes were observed. There was no loss of appetite or weight loss. Body temperature ranged between 37.6 and 38.6°C in RM1 and between 38.3 and 38.8°C in RM2 which is within the normal physiological range. 33 Hematological/biochemical parameters Hemograms, white blood cell counts and differentiation of white blood cells were within normal limits in both animals. Slight increases of the transaminases ASAT and ALAT and the mild increase in LDH seen in both animals may be GCV related and/or related to the frequent sedations. 34 
Viral shedding
The urine of RM1, which received the highest virus dose, collected 1 day after virus injection, appeared to be positive for the virus after 2 days of culture. However, the 5 days culture was negative indicating either the possibility of a false-positive result or the presence of the virus in a low amount in the 2 days culture. Cultures of urine samples of this animal collected at days 2, 3, 4 and 5 were negative. All stool cultures and pharyngeal swab cultures were negative as well.
Antibodies
Before treatment no antibodies to adenovirus were present in the sera of the monkeys. Using the complement fixation assay no antibodies were detected up to 14 days after virus administration.
Histopathological examination of the brain
The histopathological findings were essentially the same in both animals. On gross examination of the brain the site of virus injection was indicated by a softening on the surface of the right frontal lobe (Figure 1a ). The site of PBS injection (left frontal lobe) was hardly distinguishable. Macroscopically, a coronal section of the brain showed a 5 mm pigmented lesion in the white matter of the frontal lobe at the site of the virus injection ( Figure  1b) . On microscopical examination we found an area of necrosis surrounded by inflammatory infiltrates and reactive gliosis. Although the infiltrates mainly consisted of mononuclear cells, some polynuclear cells and hemosiderin-containing macrophages were present. Around the lesion we observed a trace of edema and also some perivascular cuffs consisting of mononuclear cells (Figure 2a  and b) . The perivascular cells did not invade the vessel walls. In RM1 the infiltrate reached the ventricle causing a localized ependymitis. The choroid plexus of this animal remained entirely normal. The animal which received the highest virus dose per volume (RM2) showed a localized meningitis in the vicinity of the injection site, most likely resulting from backflow of the virus along the needle tract. The extent of inflammatory changes suggested penetration of the vector in at least a 20 mm diameter area. At the PBS injection site gliosis and some inflammatory cells were present. In both animals cerebellum, brainstem and spinal cord were free of infiltrates, perivascular cuffs or gliosis.
Immunohistochemistry (Figures 3a-f)
Around the lesion reactive astrocytes and macrophages were seen. The perivascular cuffs around vessels in the immediate vicinity of the lesion contained T lymphocytes and clusters of B lymphocytes were observed. The inflammatory cells did not invade the vessel walls. The infiltrate tapered off with increasing distance to the lesion.
Discussion
After injection of a high dose of IG.Ad.MLPI.TK into the brain of nonhuman primates, followed by systemic ganciclovir administration, we observed no clinical signs, especially no focal neurological deficits or seizures. Despite this favourable clinical course, however, notable histopathological changes were found at necropsy, 18 days after injection.
The histopathological findings in the brains of the animals were characterized by a local necrosis with macrophages and some granulocytes at the injection site. This area was surrounded by gliosis and mononuclear infil-b a
Figure 2 HE staining of the brain at the site of vector administration. An area of necrosis (N) is surrounded by inflammatory cells (a). In the vicinity of the lesion perivascular cuffs consisting of mononuclear cells are seen (b).
trates. Immunohistochemical analyses revealed predominantly T lymphocytes although a considerable number of B cells (especially perivascular) was present as well. Mild meningitis was observed in RM2 and a mild ependymitis, due to spread of the infiltrate, in RM1.
Similar histopathological results have been reported by Smith et al 35 who administered even higher doses of adenotk into rhesus monkey brains than we did. In contrast, one out of two baboons treated by Goodman et al 32 that received 1.5 × 10 9 plaque forming units (p.f.u.) (3 × 10 10 particles) adenotk combined with GCV died at day 5 because of herniation of the brain as a result of massive edema. Because of severe clinical toxicity the second animal had to be killed at day 8. At necropsy, 1.5-2.0-cm necrotic cavities were found and microscopical examination of this area disclosed polymorphonuclear and mononuclear infiltrates. Perivascular infiltrates were associated with endothelial cell loss.
There is no straightforward explanation for the differences in outcome between these experiments. The obvious differences between the three experiments are: (1) the test species: rhesus monkey versus baboon; and (2) the viral construct 'as such' (see Table 1 ). As adenoviral backbone, Goodman et al used the plasmid pJM17 which is derived from the dl 309 mutant adenovirus. This mutant virus contains a 646 base pairs long insert fragment in the E3 region. The insert originates from salmon sperm DNA and interrupts the expression of the E3B 10.4K 14.6K and 14.7K genes, but not of the 19K gene. 36, 37 The vector used by Smith et al is based on adenovirus sub360 and contains a deletion in the 14.6 kDa protein of E3B. 38 We used the ClaI fragment of wild-type Ad5 as adenoviral backbone, leaving the entire E3 region intact.
As in standard neurosurgical practice, our animals received dexamethasone perioperatively. Despite this, we did not find significant differences in outcome between our study and the study of Smith et al who used no steroids. In addition, those authors observed no important differences in the pathologic findings after intracerebral adenovirus administration in Wistar rats receiving dexamethasone compared with those that did not receive dexamethasone. 35 This may indicate the limited influence of the perioperative use of steroids. However, at this time, the contribution of the immune response in the elimination of established brain tumors using the HSVtk/GCV system is not known. Several experiments have demonstrated that intracerebral injection of adenotk produces histopathological changes in a dose-dependent fashion. In Fischer rats, intracerebral injection of 1 × 10 8 IU IG.Ad.MLPI.TK results in some glial proliferation and a few mononuclear cells along the needle tract. However, a dose of 1 × 10 9 IU recombinant adenoviral particles produces focal malacia and mononuclear infiltrates spreading along the white matter tract. 39 Comparable dose-dependent changes were reported by Smith et al 35 in Wistar rats and in rhesus monkeys. Also, Goodman et al 32 observed severe clinical and neuropathological toxicity in high-dose monkeys only.
The effects of adenotk/GCV are relatively more pronounced in nonhuman primates than in rats. In Wistar (Smith et al) and Fischer (Vincent et al) rats, intracerebral administration of approximately 1 × 10 8 IU adenotk resulted in mild focal neuropathological changes.
In baboons (Goodman et al) and rhesus monkeys (Smith et al and the present study) this dose resulted in notable edema visualized on MRI while microscopical examination also revealed foci of necrosis, macrophage infiltration and perivascular lymphocytic cuffing.
In vitro studies clearly showed a higher transduction efficiency and more toxicity of recombinant adenovirus in human than in rat cell lines. 39 Similarly, in vivo nonhuman primates seem to be more susceptible to the vector as compared with rats. At present we do not know how toxicity in rats and monkeys will relate to toxicity in humans.
The in vivo toxicity of recombinant adenoviral vectors has been attributed to direct toxic qualities of the adenoviral particles and to the immunological response elicited by the virus. The immune response to the adenovirus displays a biphasic pattern: an early innate response followed by a T cell-mediated phase. The aspecific early response is induced by the toxic properties of the virus particles and can be elicited by UV inactivated viruses Table 2 .
Activated astrocytes (gliosis) around the lesion are seen by using anti-GFAP antibodies (a). Staining of macrophages (b), leukocytes (c), T lymphocytes (d) and B lymphocytes (e and f). Note that B cells are only seen in perivascular cuffs. Antibodies used for immunohistochemical staining are summarized in
both in peripheral organs and in the brain. 25, 30 Most likely, fiber and/or hexon proteins stimulate cytokine release, resulting in increased levels of TNF-␣, IL-1 and IL-6. 40 Recently, a critical role in acute inflammation has been suggested for adenovirus-induced IL-8 production. 41, 42 All these cytokines stimulate chemotaxis and are involved in the recruitment of immune cells. In rat and mouse lung and liver tissue this phase is characterized by the presence of mononuclear cells (especially macrophages) and polymorphonuclears. 30, 43 After virus injection into the rat brain, however, polymorphonuclear cells are almost always absent. 25, 29 The second phase of the immune response is often attributed to low level expression of viral proteins. 30 Recent experiments, however, have shown the importance of the immunogenicity of the (non-self) transgene- encoded protein rather than the viral proteins in eliciting this inflammatory reaction. [44] [45] [46] [47] Taking the different experiments together, Morral et al 46 stressed the importance of the concomitant response to adenoviral and foreign proteins. In cancer gene therapy, the intra-tumor induction of a strong immune response directed against viral and/or transgene encoded proteins may be favorable.
In our animal study we tried to mimic the clinical situation. In this case toxic effects can be considered as the sum of the immune response to the vector and/or thymidine kinase (which is known to be immunogenic) and the TK/GCV action. 48 Clinically, we did not observe signs of early or late toxicity. Microscopical examination of the brains was limited to day 18 and revealed macrophages and polymorphonuclear cells, probably as a part of the ubiquitous and aspecific scavenger reaction which is elicited by necrotic tissue. However, the mononuclear cells observed are most likely part of the adaptive phase. The (perivascular) B lymphocytes may indicate a local antibody synthesis.
From this preclinical study in nonhuman primates we conclude that treatment of patients with malignant gliomas using adenotk/GCV may be feasible. However, careful dose-finding in clinical studies is recommended.
Materials and methods
Viral construct
Recombinant adenoviruses harboring the HSVtk gene (IG.Ad.MLPI.TK) were made from plasmid pMLP.TK in which HSVtk expression is driven by the adenovirusderived major late promoter and transcription is terminated by the SV40 polyadenylation signal. 9, 49 The vector used in this experiment, IG.Ad.MLPI.TK is similar to the previously described IG.Ad.MLP.TK except that it has an extended deletion of the E1 region (⌬E1 459-3510), removing all E1 protein coding sequences from the vector. Furthermore, 71 nucleotides of 3Ј untranslated lacZ sequences present in IG.Ad.MLP.TK due to cloning procedures were removed in IG.Ad.MLPI.TK. Otherwise, the vectors were similar as judged by expression levels of tk, production yields and pIX protein synthesis in E1 complementing cell lines (data not shown).
Recombinant viruses were generated by cotransfecting E1 complementing cells with SalI-linearized pMLPI.TK and the large ClaI fragment of wild-type Ad5 DNA. Recombinant viruses were plaque purified twice, propagated and titrated according to standard procedures. 
Shedding
Culture of recombinant adenovirus is extensively described elsewhere. 51 Presence of virus in urine and stool samples and pharyngeal swabs was tested by culture on 293 and Hep2 indicator cells. After 2 and 5 days incubation, the cells were assayed for the presence of recombinant adenovirus by indirect immunofluorescence using a genus-specific monoclonal antibody: MAd-g1 (isotype, IgG 2a ). 52 Immunohistochemistry Immunohistochemistry was performed on 5 m sections. The slides were deparaffinized and endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol, followed by preincubation with 5% normal goat serum (Dako, The Netherlands) diluted in phosphate-buffered saline and bovine serum albumin (PBS-BSA) for 15 min at 37°C. All incubations were performed in a humidifying chamber. The primary antibodies were anti-glial fibrillary acidic protein (GFAP), anti-CD68, anti-CD45, anti-CD8 and anti-CD20 ( Table 2 ). The sections were preincubated with the indicated amounts of the antibodies for 1 h at RT followed by incubation with biotinylated goat anti-rabbit antibody or biotinylated rat anti-mouse antibody (Dako), diluted 1:400 in PBS, for 30 min. Next, the sections were incubated with streptavidinbiotin-alkaline phosphatase complex (Dako) for 30 min and the substrate reaction was visualized for alkaline phosphatase (Vector Kit, Vector Laboratories, Burlingame, CA, USA). Between steps, the sections were washed 3 × 5 min in PBS. The slides were lightly counterstained with hematoxylin.
Animals and surgical procedure Two adult male rhesus monkeys (Macaca mulatta) weighing 8.1 (RM1, BPRC code 8961) and 7.1 kg (RM2, BPRC code A100), respectively, were treated. Experiments were approved by the Institutional Animal Care and Use Committee of the Biomedical Primate Research Center, Rijswijk. During the experiment the animals were housed under D-II containment.
Before treatment no antibodies to adenovirus were detected in the sera of these monkeys and hematological and biochemical parameters were within the normal range. The surgical procedure was performed under aseptic conditions. Around the procedure the animals received dexamethasone, to prevent brain edema, and Synulox (amoxicillin/clavulanate) (Smith-KleinBeecham, Zoetermeer, The Netherlands). The animals were sedated with ketamine (10 mg/kg, i.m.) followed by general inhalational anesthesia with 1% isoflurane. A stereotactic frame (David Kopf Instruments, Tajunga, CA, USA) was used to fix the skull of the monkey. Two 2.5 mm holes were drilled into the skull, 20 mm anterior to the intra-aural line and 6 mm right and left lateral to the midline. The vector suspension was injected into the deep white matter of the right frontal lobe, 10 mm below the cortex of the brain. 53 As a control, PBS was injected at the same place in the opposite hemisphere. Vector and PBS were injected over an 8-min period using a Hamilton syringe which was fitted to the frame and connected to a 26-gauge needle. The needle was slowly withdrawn over another 2-3-min period. particles) in a volume of 250 l. As a control the same volume of PBS was injected into the contralateral hemisphere, 100 l and 250 l, respectively. Forty-eight hours after vector injection, ganciclovir (GCV) was administered (10 mg/kg, i.v., once a day, in 100 ml NaCl 0.9%) for 14 days. For GCV administration, the animals were sedated daily (ketamin) and during a 30-min period the drug was slowly infused via one of the limb veins. The animals were observed daily to assess general condition (also checked by daily measurement of body temperature and weight). Special attention was paid to neurological status and behaviour. During the first 5 days dexamethasone was given, starting with a dose of 2 mg/kg/day, i.m. which was gradually tapered and discontinued at day 6. Dexamethasone was administered because this study was designed to mimic the clinical situation as closely as possible. The use of steroids is standard in neurosurgical practice. Synulox (10 mg/kg/day, i.m.) was given during the first 10 days. From day 1 to day 5, daily urine and stool samples and pharyngeal swabs were cultured to see whether there was any viral shedding. Blood samples were taken before treatment and 3, 7 and 14 days after virus injection. Samples were tested for hemogram and for blood chemistry to monitor liver and renal function. Neutralizing antibodies to adenovirus were determined by complement fixation assay (before treatment and day 14, according to routine procedures at the Diagnostic Center SSDZ, Delft, the Netherlands). At day 18, the animals were killed by an overdose of pentobarbital. The brain was flushed by bilateral carotid perfusion with heparin (5 U/ml) containing PBS followed by perfusion fixation with formalin 4% and postfixation in formalin 4% for 2-3 weeks. After paraffin-embedding, 10 and 5 m coronal sections of the brain were cut and stained with hematoxylin and eosin or used for immunohistochemistry.
